Photo from wikipedia
To assess the efficacy of intravenous ferric carboxymaltose (IV FCM) for the treatment of iron deficiency anemia (IDA) diagnosed de novo in the third trimester of pregnancy. Click to show full abstract
To assess the efficacy of intravenous ferric carboxymaltose (IV FCM) for the treatment of iron deficiency anemia (IDA) diagnosed de novo in the third trimester of pregnancy.
Keywords:
deficiency anemia;
iron deficiency;
third trimester;
ferric carboxymaltose;
treatment iron;
trimester pregnancy
Journal Title: Journal of Obstetrics and Gynaecology Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Obstetrics and Gynaecology Research
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!